Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series

OBJECTIVE: To assess the real-world effectiveness and safety of single injection of a fluocinolone acetonide (FAc) implant in previously treated patients with recurrent diabetic macular oedema (DMO) over a 36-month follow-up period. METHODS AND ANALYSIS: This is a retrospective study conducted at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Muna, Putri, Christine, Quhill, Hibba, Quhill, Fahd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337879/
https://www.ncbi.nlm.nih.gov/pubmed/32656358
http://dx.doi.org/10.1136/bmjophth-2020-000484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337879/
https://www.ncbi.nlm.nih.gov/pubmed/32656358
http://dx.doi.org/10.1136/bmjophth-2020-000484

Ejemplares similares